Publicacións nas que colabora con Luis Barral (8)

2022

  1. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

    Frontiers in Pharmacology, Vol. 13

2021

  1. Relaxin has beneficial effects on liver lipidome and metabolic enzymes

    FASEB Journal, Vol. 35, Núm. 7

2020

  1. Carrageenan-based physically crosslinked injectable hydrogel for wound healing and tissue repairing applications

    International Journal of Pharmaceutics, Vol. 589

  2. Poly(hydroxybutyrate-co-hydroxyvalerate) microparticles embedded in κ-carrageenan/locust bean gum hydrogel as a dual drug delivery carrier

    International Journal of Biological Macromolecules, Vol. 146, pp. 110-118

2019

  1. Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats

    Biochemical Pharmacology, Vol. 170

  2. Entrapment of chitosan, pectin or κ-carrageenan within methacrylate based hydrogels: Effect on swelling and mechanical properties

    Materials Science and Engineering C, Vol. 96, pp. 583-590

  3. Hydrocortisone loaded poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for topical ophthalmic administration: Preparation, characterization and evaluation of ophthalmic toxicity

    International Journal of Pharmaceutics, Vol. 568

  4. Poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/cellulose nanocrystal films: artificial weathering, humidity absorption, water vapor transmission rate, antimicrobial activity and biocompatibility

    Cellulose, Vol. 26, Núm. 4, pp. 2333-2348